Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

GeoVax Labs, Inc.

http://www.geovax.com

Latest From GeoVax Labs, Inc.

NASH Backlash: Intercept Delay Raises Questions

A complete response letter from the FDA in June knocked Intercept’s stock price down to 2014 levels, but perhaps the regulator is sending wider messages about NASH.

Liver & Hepatic Business Strategies

Seizing The Day: How Coronavirus Breaks Then Makes Vaccine Makers In China

Amid fears of a second wave of coronavirus infections and the increasing dominance of state-owned enterprises, private vaccine makers in China are struggling to make the best of the outbreak, BravoVax CEO Ke Wu tells Scrip in an exclusive interview.

Coronavirus COVID-19 China

China Second Wave Fuels Vaccines Rush, Year-End Launch Possible?

After two months of zero confirmed domestic coronavirus cases in Beijing, a new cluster of 50 fuels fears of a second wave and prompts authorities to speed up readiness through a first vaccine launch.

China Coronavirus COVID-19

China Still Leading Vaccines Race Despite Moderna Data, US 'Warp Speed' Plan?

The unveiling of US president Donald Trump’s 'Warp Speed’ plan to fast-track a coronavirus vaccine and the latest promising Phase I data from Moderna's candidate haven't seemed to swing China’s belief that it’s still leading the race.

Coronavirus COVID-19 China
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
  • Other Names / Subsidiaries
    • Dauphin Technology, Inc.
UsernamePublicRestriction

Register